BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2125741)

  • 1. [Antigens in Trypanosoma cruzi].
    Búa JE; Bontempi EJ; Ruiz AM; Segura EL
    Rev Argent Microbiol; 1990; 22(1):37-55. PubMed ID: 2125741
    [No Abstract]   [Full Text] [Related]  

  • 2. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein.
    Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC
    Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An iron-binding Trypanosoma cruzi urinary antigen.
    Corral RS; Bertot GM; Petray PB; Altcheh JM; Singh M; Orn A; Rapoport MF; Grinstein S
    Parasite; 1995 Dec; 2(4):339-44. PubMed ID: 8745735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease.
    Gruber A; Zingales B
    Exp Parasitol; 1993 Feb; 76(1):1-12. PubMed ID: 8467895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ
    Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro translation of Trypanosoma cruzi antigens recognized by human chagasic sera.
    Rangel-Aldao R; Comach G; Mendoza A
    J Parasitol; 1987 Aug; 73(4):855-7. PubMed ID: 2442341
    [No Abstract]   [Full Text] [Related]  

  • 8. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Trypanosoma cruzi, T. cruzi marinkellei, T. dionisii and T. vespertilionis by monoclonal antibodies.
    Petry K; Baltz T; Schottelius J
    Acta Trop; 1986 Mar; 43(1):5-13. PubMed ID: 2424290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
    Zingales B; Golgher DB; Marmorato PG; Souto RP; Gruber A
    Biol Res; 1993; 26(1-2):89-100. PubMed ID: 7670551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chronic presence of the parasite, and anti-P autoimmunity in Chagas disease: the Trypanosoma cruzi ribosomal P proteins, and their recognition by the host immune system.
    Kaplan D; Vazquez M; Lafon S; Schijman AG; Levitus G; Levin MJ
    Biol Res; 1993; 26(1-2):273-7. PubMed ID: 7545503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of monoclonal antibodies against the trypomastigote stage of Trypanosoma cruzi by use of iminobiotinylated surface polypeptides.
    Beard CA; Wrightsman RA; Manning JE
    Mol Biochem Parasitol; 1985 Aug; 16(2):199-212. PubMed ID: 3929088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of ribonucleoproteic antigens containing repeated amino acid sequences from Trypanosoma cruzi.
    Pais FS; DaRocha WD; Almeida RM; Leclercq SY; Penido ML; Fragoso SP; Bartholomeu DC; Gazzinelli RT; Teixeira SM
    Microbes Infect; 2008 Jun; 10(7):716-25. PubMed ID: 18538614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate immunity in American trypanosomiasis.
    Travassos LR; Almeida IC
    Springer Semin Immunopathol; 1993; 15(2-3):183-204. PubMed ID: 8256197
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
    Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi proteins which are antigenic during human infections are located in defined regions of the parasite.
    Souto-Padrón T; Reyes MB; Leguizamon S; Campetella OE; Frasch AC; de Souza W
    Eur J Cell Biol; 1989 Dec; 50(2):272-8. PubMed ID: 2516802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease].
    Gruppi A; Moretti ER; Basso B; Vottero-Cima E
    Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypanosoma cruzi tubulin eliminated in the urine of the infected host.
    Bertot GM; Corral RS; Fresno M; Rodríguez C; Katzin AM; Grinstein S
    J Parasitol; 1998 Jun; 84(3):608-14. PubMed ID: 9645865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.